Senate Files

Bills

H.R. 5074 118th Congress

Kidney PATIENT Act of 2023

Latest action, Jun 11, 2024: Reported (Amended) by the Committee on Ways and Means. H. Rept. 118-548, Part I.

How the Senate voted

The Senate hasn't taken a roll call on this bill in the Congresses covered.

45 cosponsors

Sponsored by Rep. Carter, Earl L. "Buddy" [R-GA-1] (Republican). Cosponsors by party, House members included:

  • Democrats
  • Republicans
  • Independents
Cosponsors
33 D · 12 R
  • Democrat
  • Republican
  • Independent
1 senators cosponsoring

Referred to: House: Energy and Commerce Committee; House: Ways and Means Committee

Who lobbied on it

Clients whose quarterly lobbying reports named it, each quarter.

26 clientsQ3 2023Q4 2024

The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.

AKEBIA THERAPEUTICS, INC.
6 reports
ARDELYX
RESOLUTION PUBLIC AFFAIRS, LLC
6 reports
ARDELYX, INC.
ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)
6 reports
NATIONAL MINORITY QUALITY FORUM ACTION NETWORK
INTEGRATED SOLUTIONS GROUP
6 reports
RENAL HEALTHCARE ASSOCIATION
MEHLMAN CONSULTING, INC.
6 reports
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AG
CROSSROADS STRATEGIES, LLC
6 reports
AMERICAN NEPHROLOGY NURSES ASSOCIATION
VENABLE LLP
5 reports
ARDELYX, INC.
5 reports
DIALYSIS CLINIC, INC.
HOOPER, LUNDY & BOOKMAN, P.C.
5 reports
FRESENIUS MEDICAL CARE NORTH AMERICA
5 reports
FRESENIUS MEDICAL CARE NORTH AMERICA
AVENUE SOLUTIONS
5 reports
FRESENIUS MEDICAL CARE NORTH AMERICA
FEDERAL HEALTH POLICY STRATEGIES
5 reports
KIDNEY CARE PARTNERS
FEDERAL HEALTH POLICY STRATEGIES
5 reports
KIDNEY CARE PARTNERS
AVENUE SOLUTIONS
5 reports
NATIONAL KIDNEY FOUNDATION
5 reports
The top 25 of 32 clients, by reports
ClientLobbying firmReportsReports totalingFromToSenate
AKEBIA THERAPEUTICS, INC.6$1.6MQ4 2023Q3 2024yes
ARDELYXRESOLUTION PUBLIC AFFAIRS, LLC6$0Q4 2023Q3 2024yes
ARDELYX, INC.ROBERTI GLOBAL (F/K/A ROBERTI WHITE, LLC)6$0Q4 2023Q3 2024yes
NATIONAL MINORITY QUALITY FORUM ACTION NETWORKINTEGRATED SOLUTIONS GROUP6$272KQ4 2023Q3 2024yes
RENAL HEALTHCARE ASSOCIATIONMEHLMAN CONSULTING, INC.6$420KQ4 2023Q3 2024yes
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA AGCROSSROADS STRATEGIES, LLC6$260KQ4 2023Q3 2024yes
AMERICAN NEPHROLOGY NURSES ASSOCIATIONVENABLE LLP5$150KQ4 2023Q3 2024yes
ARDELYX, INC.5$3.0MQ4 2023Q3 2024yes
DIALYSIS CLINIC, INC.HOOPER, LUNDY & BOOKMAN, P.C.5$100KQ4 2023Q3 2024yes
FRESENIUS MEDICAL CARE NORTH AMERICA5$8.3MQ4 2023Q3 2024yes
FRESENIUS MEDICAL CARE NORTH AMERICAAVENUE SOLUTIONS5$0Q4 2023Q3 2024yes
FRESENIUS MEDICAL CARE NORTH AMERICAFEDERAL HEALTH POLICY STRATEGIES5$0Q4 2023Q3 2024yes
KIDNEY CARE PARTNERSFEDERAL HEALTH POLICY STRATEGIES5$160KQ4 2023Q3 2024yes
KIDNEY CARE PARTNERSAVENUE SOLUTIONS5$350KQ4 2023Q3 2024yes
NATIONAL KIDNEY FOUNDATION5$605KQ4 2023Q3 2024yes
NONPROFIT KIDNEY CARE ALLIANCEHOOPER, LUNDY & BOOKMAN, P.C.5$450KQ4 2023Q3 2024yes
AMERICAN SOCIETY OF NEPHROLOGY4$320KQ4 2023Q3 2024yes
THE ROGOSIN INSTITUTETHE FERRARO GROUP4$120KQ1 2024Q3 2024yes
AMERICAN KIDNEY FUND3$565KQ4 2024Q3 2024yes
ARDELYX, INC.THORN RUN PARTNERS3$0Q4 2024Q3 2024yes
CORMEDIX INC.3$540KQ4 2024Q3 2024yes
DAVITA INC3$3.2MQ4 2024Q3 2024yes
KIDNEY CARE COUNCIL3$225KQ1 2024Q3 2024yes
ARDELYX INCTHE HARPLE GROUP, LLC2$0Q4 2024Q3 2024yes
ARDELYX, INC.CAPITOL CITY GROUP, LTD.2$0Q4 2024Q3 2024yes